Swayampakula Ramakanth Analyst PerformanceManaging Directo at HC WainwrightSwayampakula Ramakanth is a stock analyst at HC Wainwright focused in the healthcare sector, covering 78 publicly traded companies. Over the past year, Swayampakula Ramakanth has issued 123 stock ratings, including strong buy, buy, and hold recommendations. While full access to Swayampakula Ramakanth's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Swayampakula Ramakanth's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings473 Last 12 YearsBuy Recommendations95.12% 448 Buy RatingsCompanies Covered78 Unique Companies Ratings Distribution471RatingsDistribution of strong buy, buy, hold, and sell ratings by Swayampakula Ramakanth.RatingPercentageCount Strong Buy0.6%3 ratings Buy94.5%445 ratings Hold4.9%23 ratings Sell0.0%0 ratingsOut of 471 total stock ratings issued by Swayampakula Ramakanth at HC Wainwright, the majority (94.5%) have been Buy recommendations, followed by 4.9% Hold and 0.6% Strong Buy.Best & Worst CallsBest Call000000.0%CELCMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%HSGXMar 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ89.7% of companies on NASDAQ70 companiesNYSEAMERICAN3.8% of companies on NYSEAMERICAN3 companiesNYSE2.6% of companies on NYSE2 companiesOTCMKTS2.6% of companies on OTCMKTS2 companiesTSE1.3% of companies on TSE1 companySwayampakula Ramakanth, an analyst at HC Wainwright, currently covers 78 companies listed on NASDAQ, NYSEAMERICAN, NYSE, OTCMKTS and TSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare76 companies97.4%Technology1 company1.3%Miscellaneous1 company1.3%Swayampakula Ramakanth of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Technology and companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY38 companies48.7%PHARMACEUTICALS17 companies21.8%HEALTHCARE EQUIPMENT & SUPPLIES14 companies17.9%LIFE SCIENCES TOOLS & SERVICES5 companies6.4%HEALTHCARE TECHNOLOGY1 company1.3%IT SERVICES1 company1.3%LABORATORY APPARATUS & FURNITURE1 company1.3%Miscellaneous1 company1.3% About Swayampakula RamakanthDr. Ramakanth is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on the healthcare sector. Dr. Ramakanth’s research covers companies operating in oncology, wound health, medical devices, spine health and animal health. Dr. Ramakanth possesses over ten years of experience as a Life Sciences Equity Analyst as well as seven years of biotechnology industry experience. Prior to joining H.C. Wainwright, Dr. Ramakanth worked as a Junior Analyst at both Jefferies and Merrill Lynch covering large cap pharmaceuticals. Dr. Ramakanth was also a Junior Analyst at both First Albany and Rodman & Renshaw where he focused on biotechnology companies. Dr. Ramakanth also conducted bench research and directed a preclinical drug development group at Regeneron Pharmaceuticals, Inc. Dr. Ramakanth presented at various regional and international conferences and published in several peer-reviewed journals. Dr. Ramakanth’s educational background includes a Ph.D. in Pharmacology/Toxicology from the University of Utah, an MBA from Rutgers University, an M.S. in Pharmaceutics from Auburn University, and a B. Pharm (Hons.) from BITS, India. Dr. Ramakanth also held a post-doctoral fellowship at the University of Texas MD Anderson Cancer Center.Follow on LinkedIn Swayampakula Ramakanth's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCANFCan-Fite BioPharma9/29/2026Reiterated Rating$2.23Buy$0.0000.00% ROIUNCYUnicycive Therapeutics9/29/2026Lower Price Target$4.53$13.00Buy$0.0000.00% ROIQSIQuantum-Si9/29/2026Reiterated Rating$0.80$4.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals9/28/2026Boost Price Target$86.22$195.00Buy$0.0000.00% ROITLSITriSalus Life Sciences9/23/2026Boost Price Target$4.93$12.00Buy$0.0000.00% ROIIPHAInnate Pharma9/21/2026Reiterated Rating$1.90Buy$0.0000.00% ROIAEMDAethlon Medical9/18/2026Reiterated Rating$6.78Neutral$0.0000.00% ROICORTCorcept Therapeutics9/18/2026Reiterated Rating$113.61$165.00Buy$0.0000.00% ROIPYXSPyxis Oncology9/10/2026Boost Price Target$3.38$8.00Buy$0.0000.00% ROITLSITriSalus Life Sciences9/9/2026Initiated Coverage$4.73$11.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TLSITriSalus Life Sciences9/9/2026Initiated Coverage$4.76$11.00Buy$0.0000.00% ROIFOCLFocalTherics8/25/2026Reiterated Rating$4.18$10.00Buy$0.0000.00% ROILFWDLifeward8/21/2026Reiterated Rating$7.33$10.00Buy$0.0000.00% ROICTXRCitius Pharmaceuticals8/19/2026Reiterated Rating$0.57Buy$0.0000.00% ROIACTUActuate Therapeutics8/18/2026Reiterated Rating$0.99Buy$0.0000.00% ROIPYXSPyxis Oncology8/18/2026Reiterated Rating$3.02$7.00Buy$0.0000.00% ROIINTSIntensity Therapeutics8/18/2026Boost Price Target$4.32$7.00Buy$0.0000.00% ROIETONEton Pharmaceuticals8/14/2026Boost Price Target$40.80$70.00Buy$0.0000.00% ROICELCCelcuity8/14/2026Reiterated Rating$92.44$155.00Buy$0.0000.00% ROIETONEton Pharmaceuticals8/11/2026Boost Price Target$43.67$65.00Buy$0.0000.00% ROIIPHAInnate Pharma8/10/2026Boost Price Target$2.20$7.00Buy$0.0000.00% ROIDCTHDelcath Systems8/7/2026Reiterated Rating$15.47$32.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals8/6/2026Lower Price Target$105.79$140.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics8/6/2026Boost Price Target$112.50$158.00Buy$0.0000.00% ROIPGENPrecigen8/5/2026Boost Price Target$6.53$18.00Buy$0.0000.00% ROISOPHSOPHiA GENETICS8/5/2026Boost Price Target$6.84$14.00Buy$0.0000.00% ROIPGENPrecigen8/3/2026Reiterated Rating$6.27$14.00Buy$0.0000.00% ROICORTCorcept Therapeutics7/30/2026Boost Price Target$92.95$165.00Buy$0.0000.00% ROIVCELVericel7/28/2026Reiterated Rating$45.32$70.00Buy$0.0000.00% ROIHYFTMindWalk7/20/2026Reiterated Rating$1.46Buy$0.0000.00% ROISOPHSOPHiA GENETICS7/20/2026Initiated Coverage$5.87$12.00Buy$0.0000.00% ROICELCCelcuity7/15/2026Boost Price Target$111.05$155.00Buy$0.0000.00% ROIEVOEvotec7/15/2026Lower Price Target$2.14$4.00Buy$0.0000.00% ROICANFCan-Fite BioPharma7/2/2026Reiterated Rating$4.63$8.00Buy$0.0000.00% ROIUNCYUnicycive Therapeutics6/30/2026Lower Price Target$4.70$15.00Buy$0.0000.00% ROIABSIAbsci6/25/2026Boost Price Target$10.08$16.00Buy$0.0000.00% ROICNXUConexeu Sciences6/22/2026Initiated Coverage$13.28$20.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals6/15/2026Reiterated Rating$99.35Buy$0.0000.00% ROIHUMAHumacyte6/11/2026Boost Price Target$1.04$4.00Buy$0.0000.00% ROIACTUActuate Therapeutics6/10/2026Reiterated Rating$2.01Buy$0.0000.00% ROIThe $15 Gold Fund That Pays Up to $1,152/Month (Ad)Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.Discover the gold income fund before the next payout dateNUVLNuvalent6/9/2026Downgrade$122.82$124.00Neutral$0.0000.00% ROIINABIN8bio6/4/2026Reiterated Rating$1.54Buy$0.0000.00% ROICELCCelcuity6/3/2026Lower Price Target$91.42$145.00Buy$0.0000.00% ROICORTCorcept Therapeutics6/2/2026Boost Price Target$70.44$95.00Buy$0.0000.00% ROIMDWDMediWound5/28/2026Reiterated Rating$14.33$36.00Buy$0.0000.00% ROICORTCorcept Therapeutics5/28/2026Boost Price Target$66.65$95.00Buy$0.0000.00% ROIPGENPrecigen5/28/2026Boost Price Target$4.40$14.00Buy$0.0000.00% ROIHUMAHumacyte5/26/2026Reiterated Rating$1.09$3.00Buy$0.0000.00% ROIHYFTMindWalk5/19/2026Reiterated Rating$1.24$5.00Buy$0.0000.00% ROICELCCelcuity5/18/2026Boost Price Target$137.68$185.00Buy$0.0000.00% ROICTXRCitius Pharmaceuticals5/18/2026Reiterated Rating$0.55$4.00Buy$0.0000.00% ROIVORVor Biopharma5/18/2026Reiterated Rating$14.31$31.00Buy$0.0000.00% ROIACTUActuate Therapeutics5/18/2026Reiterated Rating$2.43$15.00Buy$0.0000.00% ROIETONEton Pharmaceuticals5/15/2026Boost Price Target$29.40$57.00Buy$0.0000.00% ROIPGENPrecigen5/14/2026Boost Price Target$4.15$11.00Buy$0.0000.00% ROICANFCan-Fite BioPharma5/12/2026Set Price Target$3.36$5.00Buy$0.0000.00% ROIVCELVericel5/8/2026Reiterated Rating$35.13$64.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals5/7/2026Set Price Target$101.07$185.00$0.0000.00% ROIBSEMBioStem Technologies5/6/2026Upgrade$4.18Strong-Buy$0.0000.00% ROICORTCorcept Therapeutics5/4/2026Boost Price Target$51.42$75.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals5/4/2026Boost Price Target$108.37$175.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals4/27/2026Boost Price Target$93.03$150.00Buy$0.0000.00% ROIEVAXEvaxion A/S4/24/2026Reiterated Rating$4.25$16.00Buy$0.0000.00% ROIACTUActuate Therapeutics4/22/2026Reiterated Rating$2.27$15.00Buy$0.0000.00% ROINUVLNuvalent4/21/2026Reiterated Rating$108.24$155.00Buy$0.0000.00% ROIVORVor Biopharma4/15/2026Lower Price Target$15.87$31.00Buy$0.0000.00% ROIACTUActuate Therapeutics4/13/2026Lower Price Target$1.72$15.00Buy$0.0000.00% ROIFOCLFocalTherics4/9/2026Lower Price Target$3.32$10.00Buy$0.0000.00% ROIRNXTRenovoRx4/8/2026Reiterated Rating$0.94$3.00Buy$0.0000.00% ROIIPHAInnate Pharma4/7/2026Reiterated Rating$1.35$5.00Buy$0.0000.00% ROIPGENPrecigen3/26/2026Boost Price Target$3.10$10.00Buy$0.0000.00% ROIOCGNOcugen3/25/2026Boost Price Target$1.92$10.00Buy$0.0000.00% ROICORTCorcept Therapeutics3/25/2026Lower Price Target$40.78$60.00Buy$0.0000.00% ROIPYXSPyxis Oncology3/24/2026Reiterated Rating$1.42$7.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals3/23/2026Reiterated Rating$88.51$130.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/20/2026Boost Price Target$22.67$52.00Buy$0.0000.00% ROILFWDLifeward3/19/2026Boost Price Target$6.72$10.00Buy$0.0000.00% ROIINABIN8bio3/13/2026Reiterated Rating$1.91Buy$0.0000.00% ROIALXOALX Oncology3/10/2026Reiterated Rating$2.13$4.00Buy$0.0000.00% ROIEVAXEvaxion A/S3/9/2026Reiterated Rating$3.22$16.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics3/9/2026Boost Price Target$77.56$130.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/2/2026Boost Price Target$16.99$37.00Buy$0.0000.00% ROIVCELVericel2/27/2026Boost Price Target$36.13$64.00Buy$0.0000.00% ROICORTCorcept Therapeutics2/20/2026Lower Price Target$34.24$67.00Buy$0.0000.00% ROIVSTMVerastem2/4/2026Initiated Coverage$6.30$18.00Buy$0.0000.00% ROIECORelectroCore1/26/2026Lower Price Target$7.47$18.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals1/26/2026Boost Price Target$94.29$130.00Buy$0.0000.00% ROICORTCorcept Therapeutics1/22/2026Boost Price Target$41.47$105.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals1/13/2026Reiterated Rating$89.50$102.00Buy$0.0000.00% ROIDCTHDelcath Systems1/9/2026Reiterated Rating$10.45$30.00Buy$0.0000.00% ROILouis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock freeCGENCompugen1/7/2026Initiated Coverage$1.55$4.00Buy$0.0000.00% ROICGENCompugen1/7/2026Initiated Coverage$1.72$4.00Buy$0.0000.00% ROICORTCorcept Therapeutics1/2/2026Lower Price Target$34.80$90.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock12/31/2025Downgrade$10.61Neutral$0.0000.00% ROIPYXSPyxis Oncology12/19/2025Boost Price Target$1.73$7.00Buy$0.0000.00% ROIABSIAbsci12/17/2025Boost Price Target$3.54$8.00Buy$0.0000.00% ROIJANXJanux Therapeutics12/2/2025Lower Price Target$33.99$45.00Buy$0.0000.00% ROIHUMAHumacyte12/1/2025Reiterated Rating$1.36$3.00Buy$0.0000.00% ROIJANXJanux Therapeutics11/25/2025Reiterated Rating$31.53$70.00Buy$0.0000.00% ROICORTCorcept Therapeutics11/25/2025Reiterated Rating$77.71$145.00Buy$0.0000.00% ROIMDWDMediWound11/21/2025Reiterated Rating$16.86$36.00Buy$0.0000.00% ROIACTUActuate Therapeutics11/19/2025Reiterated Rating$6.10$20.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock11/18/2025Set Price Target$4.18$6.00Buy$0.0000.00% ROILFWDLifeward11/18/2025Lower Price Target$7.14$54.00Buy$0.0000.00% ROICELCCelcuity11/17/2025Reiterated Rating$92.68$94.00Neutral$0.0000.00% ROINUVLNuvalent11/17/2025Boost Price Target$112.06$155.00Buy$0.0000.00% ROIPGENPrecigen11/14/2025Boost Price Target$3.86$9.00Buy$0.0000.00% ROIVORVor Biopharma11/14/2025Lower Price Target$9.75$32.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics11/10/2025Boost Price Target$36.28$47.00Buy$0.0000.00% ROIPSNLPersonalis11/6/2025Boost Price Target$7.66$10.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals11/5/2025Boost Price Target$70.97$81.00Buy$0.0000.00% ROICANFCan-Fite BioPharma11/4/2025Reiterated Rating$8.24$50.00Buy$0.0000.00% ROIUNCYUnicycive Therapeutics10/29/2025Reiterated Rating$4.72$22.00Buy$0.0000.00% ROIIPHAInnate Pharma10/29/2025Set Price Target$2.10$5.00Buy$0.0000.00% ROIVORVor Biopharma10/29/2025Boost Price Target$25.28$52.00Buy$0.0000.00% ROIIPHAInnate Pharma10/29/2025Upgrade$2.00Strong-Buy$0.0000.00% ROIDYAIDyadic International10/23/2025Initiated Coverage$1.10$3.00Buy$0.0000.00% ROICELCCelcuity10/22/2025Boost Price Target$65.50$77.00Buy$0.0000.00% ROIVSTMVerastem10/21/2025Reiterated Rating$8.02$14.00Buy$0.0000.00% ROIDCTHDelcath Systems10/20/2025Set Price Target$11.42$30.00Buy$0.0000.00% ROIEVAXEvaxion A/S10/20/2025Reiterated Rating$6.79$16.00Buy$0.0000.00% ROICORTCorcept Therapeutics10/20/2025Reiterated Rating$79.49$145.00Buy$0.0000.00% ROICORTCorcept Therapeutics10/10/2025Reiterated Rating$88.36$145.00Buy$0.0000.00% ROIEVAXEvaxion A/S9/25/2025Boost Price Target$4.00$16.00Buy$0.0000.00% ROIACTUActuate Therapeutics9/23/2025Reiterated Rating$7.09$20.00Buy$0.0000.00% ROIIPHAInnate Pharma9/18/2025Downgrade$2.05Neutral$0.0000.00% ROIPSNLPersonalis9/8/2025Reiterated Rating$5.24$8.50Buy$00.0000.00% ROIDNTHDianthus Therapeutics9/8/2025Reiterated Rating$26.50$40.00Buy$000.0000.00% ROICLGNCollPlant Biotechnologies8/21/2025Reiterated Rating$19.70$110.00Buy$0.0000.00% ROIPGENPrecigen8/19/2025Reiterated Rating$2.95$8.50Buy$0.0000.00% ROIPYXSPyxis Oncology8/19/2025Reiterated Rating$1.24$5.00Buy$0.0000.00% ROICELCCelcuity8/18/2025Boost Price Target$51.79$66.00Buy$00.0000.00% ROIACTUActuate Therapeutics8/18/2025Reiterated Rating$8.12$20.00Buy$0.0000.00% ROIAEMDAethlon Medical8/14/2025Reiterated Rating$1.23Neutral$0.0000.00% ROIVORVor Biopharma8/14/2025Reiterated Rating$40.40$60.00Buy$00.0000.00% ROIXFORX4 Pharmaceuticals8/13/2025Set Price Target$2.58$3.50Buy$0.0000.00% ROIPGENPrecigen8/13/2025Reiterated Rating$1.80$6.00Buy$0.0000.00% ROIHUMAHumacyte8/12/2025Lower Price Target$1.75$3.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals8/7/2025Boost Price Target$53.39$80.00Buy$00.0000.00% ROIDCTHDelcath Systems8/7/2025Boost Price Target$10.64$31.00Buy$00.0000.00% ROITicker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free.PSNLPersonalis8/6/2025Lower Price Target$5.64$8.50Buy$00.0000.00% ROICELCCelcuity7/28/2025Boost Price Target$39.34$50.00Buy$00.0000.00% ROIAEMDAethlon Medical7/7/2025Upgrade$1.27Neutral$0.0000.00% ROIOCGNOcugen6/24/2025Reiterated Rating$0.98$7.00Buy$0.0000.00% ROIETONEton Pharmaceuticals5/29/2025Reiterated Rating$20.08$35.00Buy$00.0000.00% ROIUNCYUnicycive Therapeutics5/27/2025Upgrade$5.53$90.00Strong-Buy$0.0000.00% ROIDCTHDelcath Systems5/23/2025Reiterated Rating$16.15$29.00Buy$00.0000.00% ROIMDWDMediWound5/22/2025Set Price Target$19.89$31.00Buy$00.0000.00% ROIMIRMMirum Pharmaceuticals5/19/2025Reiterated Rating$45.01$73.00Buy$00.0000.00% ROICELCCelcuity5/19/2025Reiterated Rating$10.61$27.00Buy$000.0000.00% ROIPYXSPyxis Oncology5/19/2025Reiterated Rating$1.21$5.00Buy$0.0000.00% ROIQSIQuantum-Si5/19/2025Reiterated Rating$1.41$5.50Buy$0.0000.00% ROIAFMDAffimed5/14/2025Downgrade$0.11Neutral$0.0000.00% ROIHUMAHumacyte5/14/2025Initiated Coverage$1.93$4.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics5/13/2025Reiterated Rating$20.08$40.00Buy$00.0000.00% ROIOCGNOcugen5/12/2025Lower Price Target$0.70$7.00Buy$0.0000.00% ROIVORVor Biopharma5/9/2025Reiterated Rating$0.16Neutral$00.0000.00% ROIALXOALX Oncology5/9/2025Lower Price Target$0.46$2.00Buy$0.0000.00% ROIPSNLPersonalis5/7/2025Boost Price Target$4.00$9.00Buy$0.0000.00% ROICORTCorcept Therapeutics5/6/2025Lower Price Target$73.94$145.00Buy$00.0000.00% ROICHRNChronoScale Corporation Common Stock5/6/2025Lower Price Target$7.15$60.00Buy$00.0000.00% ROIXFORX4 Pharmaceuticals5/2/2025Boost Price Target$3.75$7.00Buy$0.0000.00% ROIIPHAInnate Pharma4/24/2025Reiterated Rating$2.00$11.00Buy$0.0000.00% ROIEVAXEvaxion A/S4/2/2025Reiterated Rating$1.66$14.00Buy$0.0000.00% ROIMDAISpectral AI4/2/2025Reiterated Rating$1.20$3.50Buy$0.0000.00% ROICELCCelcuity4/1/2025Reiterated Rating$10.11$27.00Buy$000.0000.00% ROICORTCorcept Therapeutics3/31/2025Boost Price Target$100.43$150.00Buy$00.0000.00% ROIIPHAInnate Pharma3/28/2025Reiterated Rating$1.97$11.50Buy$0.0000.00% ROIFOCLFocalTherics3/28/2025Reiterated Rating$2.22$19.00Buy$0.0000.00% ROIRNXTRenovoRx3/27/2025Initiated Coverage$1.02$3.00Buy$0.0000.00% ROIXFORX4 Pharmaceuticals3/27/2025Reiterated Rating$8.08$45.00Buy$0.0000.00% ROIVORVor Biopharma3/21/2025Lower Price Target$17.04$260.00Buy$00.0000.00% ROIMDWDMediWound3/20/2025Reiterated Rating$18.28$25.00Buy$00.0000.00% ROIPGENPrecigen3/20/2025Reiterated Rating$1.79$6.00Buy$0.0000.00% ROIABSIAbsci3/19/2025Reiterated Rating$3.08$7.00Buy$0.0000.00% ROIPYXSPyxis Oncology3/19/2025Reiterated Rating$1.06$5.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/19/2025Reiterated Rating$14.68$33.00Buy$00.0000.00% ROIMDAISpectral AI3/18/2025Reiterated Rating$1.76$3.50Buy$0.0000.00% ROIACTUActuate Therapeutics3/17/2025Initiated Coverage$7.25$20.00Buy$0.0000.00% ROIINABIN8bio3/14/2025Lower Price Target$6.79$180.00Buy$0.0000.00% ROIECORelectroCore3/13/2025Reiterated Rating$13.00$25.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics3/12/2025Reiterated Rating$23.38$40.00Buy$00.0000.00% ROILFWDLifeward3/11/2025Reiterated Rating$15.72$156.00Buy$0.0000.00% ROIDCTHDelcath Systems3/7/2025Boost Price Target$13.22$24.00Buy$0.0000.00% ROIALXOALX Oncology3/7/2025Reiterated Rating$1.31$5.00Buy$0.0000.00% ROIOCGNOcugen3/6/2025Reiterated Rating$0.57$8.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock3/4/2025Reiterated Rating$7.23$135.00Buy$00.0000.00% ROIJANXJanux Therapeutics3/3/2025Reiterated Rating$32.89$70.00Buy$00.0000.00% ROIPSNLPersonalis2/28/2025Reiterated Rating$4.24$8.00Buy$0.0000.00% ROIVCELVericel2/28/2025Reiterated Rating$49.62$60.00Buy$00.0000.00% ROILouis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock freeCORTCorcept Therapeutics2/27/2025Reiterated Rating$63.37$115.00Buy$00.0000.00% ROIBCYCBicycle Therapeutics2/26/2025Reiterated Rating$11.10$33.00Buy$0.0000.00% ROIEVAXEvaxion A/S2/20/2025Reiterated Rating$2.55$14.00Buy$0.0000.00% ROILFWDLifeward2/20/2025Reiterated Rating$22.08$156.00Buy$0.0000.00% ROIOCGNOcugen2/13/2025Boost Price Target$0.66$8.00Buy$0.0000.00% ROIINABIN8bio2/12/2025Reiterated Rating$9.20$240.00Buy$0.0000.00% ROICORTCorcept Therapeutics2/7/2025Reiterated Rating$68.04$80.00Buy$00.0000.00% ROIXFORX4 Pharmaceuticals2/7/2025Reiterated Rating$16.50$45.00Buy$0.0000.00% ROIIPHAInnate Pharma2/6/2025Reiterated Rating$1.95$11.50Buy$0.0000.00% ROIEVAXEvaxion A/S2/3/2025Reiterated Rating$2.45$14.00Buy$0.0000.00% ROICYPHCypherpunk Technologies1/29/2025Downgrade$0.65Neutral$0.0000.00% ROIPSNLPersonalis1/27/2025Lower Price Target$6.12$8.00Buy$00.0000.00% ROIALXOALX Oncology1/24/2025Lower Price Target$1.63$5.00Buy$0.0000.00% ROIPGENPrecigen1/23/2025Reiterated Rating$1.13$6.00Buy$0.0000.00% ROIETONEton Pharmaceuticals1/23/2025Boost Price Target$15.77$33.00Buy$00.0000.00% ROIIPHAInnate Pharma1/17/2025Reiterated Rating$1.67$11.50Buy$0.0000.00% ROIABSIAbsci1/17/2025Reiterated Rating$2.80$7.00Buy$0.0000.00% ROICYPHCypherpunk Technologies1/16/2025Reiterated Rating$3.25$5.50Buy$0.0000.00% ROIVCELVericel1/15/2025Reiterated Rating$58.67$60.00Buy$00.0000.00% ROIQSIQuantum-Si1/14/2025Reiterated Rating$1.93$5.50Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock1/14/2025Reiterated Rating$10.68$135.00Buy$0.0000.00% ROIXFORX4 Pharmaceuticals1/14/2025Reiterated Rating$16.96$45.00Buy$0.0000.00% ROIDCTHDelcath Systems1/14/2025Reiterated Rating$12.79$22.00Buy$00.0000.00% ROIBCYCBicycle Therapeutics1/13/2025Reiterated Rating$14.68$33.00Buy$0.0000.00% ROIOCGNOcugen1/13/2025Reiterated Rating$0.75$7.00Buy$0.0000.00% ROIMDWDMediWound1/10/2025Reiterated Rating$16.01$25.00Buy$00.0000.00% ROIABSIAbsci1/8/2025Reiterated Rating$3.27$7.00Buy$0.0000.00% ROICORTCorcept Therapeutics10/18/2024Boost Price Target$47.17$80.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
